Ascendis Pharma A/S

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASND and other ETFs, options, and stocks.

About ASND

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. 

CEO
Jan Møller Mikkelsen
CEOJan Møller Mikkelsen
Employees
—
Employees—
Headquarters
Hellerup, Capital Region
HeadquartersHellerup, Capital Region
Founded
2006
Founded2006
Employees
—
Employees—

ASND Key Statistics

Market cap
15.04B
Market cap15.04B
Price-Earnings ratio
16.43
Price-Earnings ratio16.43
Dividend yield
—
Dividend yield—
Average volume
924.92K
Average volume924.92K
High today
$229.52
High today$229.52
Low today
$227.36
Low today$227.36
Open price
$228.03
Open price$228.03
Volume
82.45K
Volume82.45K
52 Week high
$282.15
52 Week high$282.15
52 Week low
$186.05
52 Week low$186.05

Stock Snapshot

With a market cap of 15.04B, Ascendis Pharma A/S(ASND) trades at $229.03. The stock has a price-to-earnings ratio of 16.43.

As of 2026-10-01, Ascendis Pharma A/S(ASND) stock has fluctuated between $227.36 and $229.52. The current price stands at $229.03, placing the stock +0.7% above today's low and -0.2% off the high.

The Ascendis Pharma A/S(ASND)'s current trading volume is 82.45K, compared to an average daily volume of 924.92K.

During the past year, Ascendis Pharma A/S(ASND) stock moved between $186.05 at its lowest and $282.15 at its peak.

During the past year, Ascendis Pharma A/S(ASND) stock moved between $186.05 at its lowest and $282.15 at its peak.

ASND News

Benzinga 16h
Here's How Much $1000 Invested In Ascendis Pharma 10 Years Ago Would Be Worth Today - Benzinga

...

Here's How Much $1000 Invested In Ascendis Pharma 10 Years Ago Would Be Worth Today - Benzinga
TipRanks 2d
Ascendis Pharma Closes Warrant Exercise Window, Lifts Share Capital on September 29, 2026

An update from Ascendis Pharma ( (ASND) ) is now available. On September 29, 2026, Ascendis Pharma closed an exercise window for outstanding warrants linked to...

Simply Wall St 5d
Ascendis Pharma Could Be 28% Undervalued As It Reclaims TransCon Rights

Ascendis Pharma (NasdaqGS:ASND) has just taken full control of its TransCon technology in metabolic and cardiovascular diseases after ending its collaboration w...

Ascendis Pharma Could Be 28% Undervalued As It Reclaims TransCon Rights

Analyst ratings

100%

of 21 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own ASND. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.